On August 4, 2026, the clinical trial titled "Establishment of a Sleep and Sleep-disorder Research Cohort in Patients With Neurological Disorders" was listed with a status of enrolling by invitation. The trial is registered under identifier NCT07374393 and involves corticorelin. No phase was specified for this study in the available record.
The status update indicates that participant enrollment is currently proceeding by invitation only, meaning that participants are being selected and approached rather than through open recruitment. No results have been posted as part of this update. The event data does not include information on trial design, endpoints, or expected outcomes beyond the enrollment status itself.
Corticorelin carries an approved regulatory status. This brief reports only the enrollment status change for this specific trial listing and does not describe or imply any efficacy, safety findings, or clinical conclusions related to corticorelin. Readers interested in the trial can consult the official clinical trial registry entry for further protocol details, eligibility criteria, and future updates as the study progresses.
For more background on corticorelin, including its regulatory status and general information, readers can refer to the compound overview.